MANGANESE
Aminoate de Manganèse, Ascorbate de Manganèse, Chlorure de Manganèse, Citrate de Manganèse, Complexe Aspartate de Manganèse, Dioxyde de Manganèse, Gluconate de Manganèse, Glycérophosphate de Manganèse, Manganèse, Manganese Amino Acid Chelate, Manganese Aminoate, Manganese Ascorbate, Manganese Aspartate Complex, Manganese Chloride, Manganese Chloridetetrahydrate, Manganese Citrate, Manganese Dioxide, Manganese Gluconate, Manganese Glycerophosphate, Manganese Sulfate, Manganese Sulfate Monohydrate, Manganese Sulfate Tetrahydrate, Manganeso, Manganum, Mn, Monohydrate de Sulfate de Manganèse, Sulfate de Manganèse.<br/><br/>
Uses & Effectiveness
Effective for
- Low manganese levels in the body (manganese deficiency). Taking manganese by mouth or giving manganese intravenously (by IV) helps to treat or prevent low manganese levels in the body. Also, taking manganese by mouth along with other vitamins and minerals can promote growth in children who have low levels of manganese.
Insufficient Evidence for
- Complications of lung disease (chronic obstructive pulmonary disease, COPD). Early research suggests that giving manganese, selenium, and zinc intravenously (by IV) may help people with worsened COPD to breathe on their own without help from a machine sooner.
- Osteoarthritis. Taking a specific product containing manganese, glucosamine hydrochloride, and chondroitin sulfate by mouth for 4 months improves pain and the ability to do normal activities in people with osteoarthritis of the knee and the lower back. However, many studies show that taking glucosamine plus chondroitin without manganese can help treat osteoarthritis. Therefore, the effects of manganese are unclear.
- Weak bones (osteoporosis). Taking manganese by mouth in combination with calcium, zinc, and copper seems to help reduce spinal bone loss in older women. Also, taking a specific product containing manganese, calcium, vitamin D, magnesium, zinc, copper, and boron for one year seems to improve bone mass in women with weak bones. However, many studies show that taking calcium plus vitamin D without manganese can help treat osteoporosis. Therefore, the effects of manganese are unclear.
- Premenstrual syndrome (PMS). Early research shows that taking manganese along with calcium helps improve symptoms of PMS, including pain, crying, loneliness, anxiety, restlessness, irritability, mood swings, depression, and tension. Researchers aren’t sure whether the improvement is due to the calcium, manganese, or the combination.
- Weight loss. Early research shows that taking a specific product containing manganese, 7-oxo-DHEA, L-tyrosine, asparagus root extract, choline bitartrate, inositol, copper gluconate, and potassium iodide by mouth for 8 weeks can slightly reduce weight in overweight people.
- Wound healing. Early research shows that applying a dressing containing manganese, calcium, and zinc to chronic wounds for 12 weeks may improve wound healing.
- Anemia.
- Other conditions.
Side Effects & Safety
Manganese is LIKELY SAFE for most adults when taken by mouth in amounts up to 11 mg per day. However, people who have trouble getting rid of manganese from the body, such as people with liver disease, may experience side effects when taking less than 11 mg per day.Taking more than 11 mg per day by mouth is POSSIBLY UNSAFE for most adults.
Manganese is LIKELY UNSAFE when inhaled by adults for long periods of time. Excess manganese in the body can cause serious side effects, including symptoms resembling Parkinson's disease, such as shaking (tremors).
Special Precautions & Warnings:
Children: Taking manganese by mouth is LIKELY SAFE for children 1 to 3 years in amounts less than 2 mg per day; for children 4 to 8 years in amounts less than 3 mg per day; in children 9 to 13 years, less than 6 mg per day; and in children 14 to 18 years, less than 9 mg per day. Manganese in higher doses than described is POSSIBLY UNSAFE. Talk with your healthcare professional before giving manganese to children. High doses of manganese might cause serious side effects. Manganese is LIKELY UNSAFE when inhaled by children.Pregnancy and breast-feeding: Manganese is LIKELY SAFE in pregnant or breast-feeding adult women aged 19 or older when taken by mouth in doses of less than 11 mg per day. However, pregnant and lactating women under age 19 should limit doses to less than 9 mg per day. Manganese is POSSIBLY UNSAFE when taken by mouth in higher doses. Doses over 11 mg per day are more likely to cause serious side effects. Manganese is LIKELY UNSAFE when inhaled for long periods of time.
Long-term liver disease: People with long-term liver disease have trouble getting rid of manganese. Manganese can build up in these people and cause shaking, mental problems such as psychosis, and other side effects. If you have liver disease, be careful not to get too much manganese.
Iron-deficiency anemia: People with iron-deficiency anemia seem to absorb more manganese than other people. If you have this condition, be careful not to get too much manganese.
Nutrition that is given intravenously (by IV). People who receive nutrition intravenously (by IV) are at an increased risk of side effects due to manganese.
Interactions
Moderate Interaction
Be cautious with this combination
-
Antibiotics (Quinolone antibiotics) interacts with MANGANESE
Manganese might decrease how much antibiotic the body absorbs. Taking manganese along with some antibiotics might decrease the effectiveness of some antibiotics. To avoid this interaction take manganese supplements at least one hour after antibiotics.<br /><br /> Some of these antibiotics that might interact with manganese include ciprofloxacin (Cipro), enoxacin (Penetrex), norfloxacin (Chibroxin, Noroxin), sparfloxacin (Zagam), trovafloxacin (Trovan), and grepafloxacin (Raxar).
-
Antibiotics (Tetracycline antibiotics) interacts with MANGANESE
Manganese can attach to tetracyclines in the stomach. This decreases the amount of tetracyclines that can be absorbed. Taking manganese with tetracyclines might decrease the effectiveness of tetracyclines. To avoid this interaction take manganese two hours before or four hours after taking tetracyclines.<br /><br /> Some tetracyclines include demeclocycline (Declomycin), minocycline (Minocin), and tetracycline (Achromycin).
Dosing
The following doses have been studied in scientific research:
ADULTS
BY MOUTH:
- General: No recommended dietary allowances (RDA) for manganese have been established. When there are no RDAs for a nutrient, the Adequate Intake (AI) is used as a guide. The AI is the estimated amount of the nutrient that is used by a group of healthy people and assumed to be adequate. The daily Adequate Intake (AI) levels for manganese are: infants birth to 6 months, 3 mcg; 7 to 12 months, 600 mcg; children 1 to 3 years, 1.2 mg; 4 to 8 years 1.5 mg; boys 9 to 13 years, 1.9 mg; boys 14 to 18 years, 2.2 mg; girls 9 to 18 years, 1.6 mg; men age 19 and older, 2.3 mg; women 19 and older, 1.8 mg; pregnant women age 14 to 50, 2 mg; breastfeeding women, 2.6 mg.
- Tolerable Upper Intake Levels (UL), the highest level of intake at which unwanted side effects are not expected, for manganese have been established. The daily ULs for manganese are: children 1 to 3 years, 2 mg; 4 to 8 years, 3 mg; 9 to 13 years, 6 mg; 14 to 18 years (including pregnant and breastfeeding women), 9 mg; for adults 19 years and older (including pregnant and breast-feeding women), 11 mg.
- For low manganese levels in the body (manganese deficiency): For preventing manganese deficiency in adults, total parenteral nutrition containing 200 mcg of elemental manganese per day has been used.
BY MOUTH:
- General: No recommended dietary allowances (RDA) for manganese have been established. When there are no RDAs for a nutrient, the Adequate Intake (AI) is used as a guide. The AI is the estimated amount of the nutrient that is used by a group of healthy people and assumed to be adequate. In infants and children, the daily Adequate Intake (AI) levels for manganese are: infants birth to 6 months, 3 mcg; 7 to 12 months, 600 mcg; children 1 to 3 years, 1.2 mg; 4 to 8 years 1.5 mg; boys 9 to 13 years, 1.9 mg; boys 14 to 18 years, 2.2 mg; and girls 9 to 18 years, 1.6 mg. Tolerable Upper Intake Levels (UL), the highest level of intake at which unwanted side effects are not expected, for manganese have been established. The daily ULs for manganese for children are: children 1 to 3 years, 2 mg; 4 to 8 years, 3 mg; 9 to 13 years, 6 mg; and 14 to 18 years (including pregnant and breastfeeding women), 9 mg.
- For low manganese levels in the body (manganese deficiency): For preventing manganese deficiency in children, total parenteral nutrition containing 2-10 mcg of elemental manganese per day has been used.
REFERENCES:
- Kalman, D. S., Feldman, S., Feldman, R., Schwartz, H. I., Krieger, D. R., and Garrison, R. Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial. Nutr J 2008;7:11. View abstract.
- Campus G, Cagetti MG, Cocco F, Sale S, Sacco G, Strohmenger L, Lingström P. Effect of a sugar-free chewing gum containing magnolia bark extract on different variables related to caries and gingivitis: a randomized controlled intervention trial. Caries Res. 2011;45(4):393-9. View abstract.
- De Franciscis P, Grauso F, Luisi A, Schettino MT, Torella M, Colacurci N. Adding Agnus Castus and Magnolia to Soy Isoflavones Relieves Sleep Disturbances Besides Postmenopausal Vasomotor Symptoms-Long Term Safety and Effectiveness. Nutrients. 2017;9(2):129. View abstract.
- Coniglio SJ, Lewis JD, Lang C, et al. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr 2001;138:649-55. View abstract.
- Horvath K, Stefatos G, Sokolski KN. Improved social and language skills after secretin administration. J Assoc Acad Minor Phys 1998;9:9-15. View abstract.
- Jowell PS, Robuck-Mangum G, Mergener K, et al. A double-blind, randomized, dose response study testing the pharmacological efficacy of synthetic porcine secretin. Aliment Pharmacol Ther 2000;14:1679-84.. View abstract.
- Lightdale JR, Hayer C, Duer A, et al. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Pediatrics 2001;108:90. View abstract.
- Mulvihill SJ, Debas HT. Regulatory peptides in the gut. In: Greenspan FS, Strewler GJ, Eds. Basic & Clinical Endocrinology. 5th ed. Stamford, CT: Appleton & Lange, 1997:581.
- Roberts W, Weaver L, Brian J, et al. Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo-controlled trial. Pediatrics 2001;107:e71.
- Sandler AD, Sutton KA, DeWeese J, et al. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med 1999;341(24):1801-6. View abstract.
- Secretin for the treatment of autism. Pharmacist's Letter/Prescriber's Letter 1998;14(12):141212.
- Feng WS, He YH, Zheng XK, Wang JC, Cao YG, Zhang YL, Song K. Four New Monoterpenoid Glycosides from the Flower Buds of Magnolia biondii. Molecules. 2016 Jun 3;21(6). pii: E728. View abstract.
- Garrison R, Chambliss WG. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern Ther Health Med 2006;12:50-4. View abstract.
- Ghys K, De Palma A, Vandevenne A, Werbrouck J, Goossens A. Magnolia officinalis bark extract, a recently identified contact allergen in 'anti-ageing' cosmetics. Contact Dermatitis. 2015 Aug;73(2):130-2. View abstract.
- Hellström MK, Ramberg P. The effect of a dentifrice containing Magnolia extract on established plaque and gingivitis in man: a six-month clinical study. Int J Dent Hyg. 2014 May;12(2):96-102. View abstract.
- Hou YC, Chao PD, Chen SY. Honokiol and magnolol increased hippocampal acetylcholine release in freely-moving rats. Am J Chin Med 2000;28:379-84. View abstract.
- Jung KY, Kim DS, Oh SR, et al. Magnone A and B, novel anti-PAF tetrahydrofuran lignans from the flower buds of Magnolia fargesii. J Nat Prod 1998;61:808-11. View abstract.
- Kuribara H, Kishi E, Hattori N, et al. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 2000;52:1425-9. View abstract.
- Kuribara H, Kishi E, Maruyama Y. Does dihydrohonokiol, a potent anxiolytic compound, result in the development of benzodiazepine-like side effects? J Pharm Pharmacol 2000;52:1017-22. View abstract.
- Maruyama Y, Kuribara H, Kishi E, et al. Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments. J Pharm Pharmacol 2001;53:721-5. View abstract.
- Nakazawa T, Yasuda T, Ohsawa K. Metabolites of orally administered Magnolia officinalis extract in rats and man and its antidepressant-like effects in mice. J Pharm Pharmacol 2003;55:1583-91. View abstract.
- Nilausen TD, Johansen JD, Thyssen JP. Allergic contact dermatitis of the face caused by Magnolia officinalis bark extract. Contact Dermatitis. 2016;75(6):385-87. View abstract.
- Poivre M, Duez P. Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B. 2017;18(3):194-214. View abstract.
- Porciani PF, Grandini S, Chazine M. The effect of zinc lactate and magnolia bark extract added tablets on volatile sulfur-containing compounds in the oral cavity. J Clin Dent. 2014;25(3):53-6. View abstract.
- Porciani PF, Grandini S. The effect of zinc acetate and magnolia bark extract added to chewing gum on volatile sulfur-containing compounds in the oral cavity. J Clin Dent. 2012;23(3):76-9. View abstract.
- Raison-Peyron N, Césaire A, Du-Thanh A, Dereure O. Allergic contact dermatitis caused by Magnolia officinalis bark extract in a facial anti-ageing cream. Contact Dermatitis. 2015 Jun;72(6):416-7. View abstract.
- Schifano F, Guarino V, Papanti DG, Baccarin J, Orsolini L, Corkery JM. Is there a potential of misuse for Magnolia officinalis compounds/metabolites? Hum Psychopharmacol Clin Exp. 2017;32:e2595. View abstract.
- Shahbazi F, Sadighi S, Dashti-Khavidaki S, et al. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res. 2015;29(7):1046-53. View abstract.
- Tachikawa E, Takahashi M, Kashimoto T. Effects of extract and ingredients isolated from Magnolia obovata thunberg on catecholamine secretion from bovine adrenal chromaffin cells. Biochem Pharmacol 2000;60:433-40. View abstract.
- Talbott SM, Talbott JA, Pugh M. Effect of Magnolia officinalis and Phellodendron amurense (Relora®) on cortisol and psychological mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10(1):37. View abstract.
- Teng CM, Chen CC, Ko FN, et al. Two antiplatelet agents from Magnolia officinalis. Thromb Res 1988;50:757-65. View abstract.
- Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060-4. View abstract.
- Young DS. Effects of Drugs on Clinical Laboratory Tests 4th ed. Washington: AACC Press, 1995.
- Zhou JR, Erdman JW Jr. Phytic acid in health and disease. Crit Rev Food Sci Nutr 1995;35:495-508. View abstract.
Vitamins Survey
Have you ever purchased MANGANESE?
Did you or will you purchase this product in-store or online?
Where did you or where do you plan to purchase this product?
Where did you or where do you plan to purchase this product?
What factors influenced or will influence your purchase? (check all that apply)
Vitamins Survey
Where did you or where do you plan to purchase this product?
Do you buy vitamins online or instore?
What factors are most important to you? (check all that apply)